These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36846425)

  • 21. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Brody RM; Shimunov D; Cohen RB; Lin A; Lukens JN; Hartner L; Aggarwal C; Duvvuri U; Montone KT; Jalaly JB; LiVolsi VA; Carey RM; Shanti RM; Rajasekaran K; Chalian AA; Rassekh CH; Cannady SB; Newman JG; O'Malley BW; Weinstein GS; Gimotty PA; Basu D
    Oral Oncol; 2022 Apr; 127():105798. PubMed ID: 35245888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
    Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
    Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study.
    Davies JC; Husain Z; Day TA; Graboyes EM; Eskander A
    Front Oncol; 2021; 11():808465. PubMed ID: 35071012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of transoral robotic surgery in treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Chen SW; Yang ZY; Chen JT; Su X; Yang AK; Song M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 57(5):545-551. PubMed ID: 35610671
    [No Abstract]   [Full Text] [Related]  

  • 33. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do We Have Enough Evidence to Specifically Recommend Transoral Robotic Surgery in HPV-Driven Oropharyngeal Cancer? A Systematic Review.
    De Virgilio A; Costantino A; Rizzo D; Crescio C; Gallus R; Spriano G; Mercante G; Festa BM; Accorona R; Pignataro L; Capaccio P; Bussu F
    Pathogens; 2023 Jan; 12(2):. PubMed ID: 36839432
    [No Abstract]   [Full Text] [Related]  

  • 38. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the role of the self-assembling topical haemostat PuraBond® in Transoral Robotic Surgery (TORS) for oropharyngeal cancer: A case series.
    Gupta KK; Garas G; Idle M; Germain S; De M
    Ann Med Surg (Lond); 2022 Aug; 80():104302. PubMed ID: 36045860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Yu AC; Afework DD; Goldstein JD; Abemayor E; Mendelsohn AH
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1029-1037. PubMed ID: 36136328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.